Fate Therapeutics
FATE
$1.52
Share price
-5.00%
Change (1 day)
-60.62%
Change (1 year)
Categories
Number of shares outstanding for Fate Therapeutics (FATE)
Number of shares outstanding as of June 2025 : 118,375,540
According to Fate Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 118,375,540. At the end of 2025 the company had 118,375,540 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Fate Therapeutics from 2012 to 2025
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 0.11 B | 0.49% |
| 2024 | 0.11 B | 19.51% |
| 2023 | 98.56 M | 1.39% |
| 2022 | 97.22 M | 1.5% |
| 2021 | 95.78 M | 9.65% |
| 2020 | 87.35 M | 15.56% |
| 2019 | 75.59 M | 17.03% |
| 2018 | 64.59 M | 47.86% |
| 2017 | 43.68 M | 17.38% |
| 2016 | 37.21 M | 29.73% |
| 2015 | 28.68 M | 39.93% |
| 2014 | 20.5 M | 7.02% |
| 2013 | 19.15 M | 116.04% |
| 2012 | 8.86 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | 97,362,000 | -17.75% | 🇺🇸 USA |
 Becton Dickinson BDX | 287,293,000 | 142.70% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | 78,115,836 | -34.01% | 🇺🇸 USA |
 Avidity Biosciences RNA | 129,232,000 | 9.17% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 99,700,000 | -15.78% | 🇺🇸 USA |